Nasal Cannula is a device used by patients suffering from respiratory diseases. It supplies oxygen or increases the airflow of oxygen. The device is made up of lightweight plastic or silicon tubes that are split into two prongs which are placed in the nostrils of the patient for oxygen supply. As per a study published by the National Center for Biotechnology (NCBI), 39% of COVID-19 patients suffered from acute respiratory distress syndrome.
As of 2021 The global Nasal Cannula Market is estimated to be valued at US$ 6,801.7 Million and is expected to exhibit a CAGR of 6.4% during the years (2021-2028).
Market Leaders in the Nasal Cannula Industry:
1) Sorin Group
Sorin Group was a medical products company situated in Italy. It conducted noteworthy operations in France, America and Japan. The products manufactured include Replacement heart valves, cardiothoracic surgery accessories, data monitoring, autotransfusion systems and cannulae. The company was founded in the year 1956. The headquarters are located in Milan, Italy. The company was founded by Fiat and Montedison that were the two largest industrial groups at that time.
2) Edward Lifesciences
Edward Lifesciences is an American medical technology company that developed the SAPIEN transcatheter aortic heart valve made of cow tissue. The company was founded in the year 1958. The headquarters are located in Irvine, California. The company was founded by Miles “Lowell” Edwards. Products manufactured include Heart Valves, Critical care technology, Cardiac surgery technology.
